Reports - Gene Therapy Market
HealthcareGene Therapy Market
Gene Therapy Market Valuation and Future Projections to 2035 by Vector Type (Viral Vector, Non-Viral Vector) by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors) by Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Gene Therapy Market - Segment Analysis
1. Overview
2. Global Gene Therapy Market, 2021 - 2034 (USD Million)
3. Global Gene Therapy Market - by Vector Type
3.1. By Viral Vector
3.2. By Non-Viral Vector
4. Global Gene Therapy Market - by Gene Type
4.1. By Antigen
4.2. By Cytokine
4.3. By Tumor Suppressor
4.4. By Suicide
4.5. By Deficiency
4.6. By Growth Factors
4.7. By Receptors
5. Global Gene Therapy Market - by Application
5.1. By Oncological Disorders
5.2. By Rare Diseases
5.3. By Cardiovascular Diseases
5.4. By Neurological Disorders
5.5. By Infectious Disease
6. Global Gene Therapy Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Gene Therapy Market - Segment Analysis
1. Overview
2. North America Gene Therapy Market, 2021 - 2034 (USD Million)
3. North America Gene Therapy Market - by Vector Type
3.1. By Viral Vector
3.2. By Non-Viral Vector
4. North America Gene Therapy Market - by Gene Type
4.1. By Antigen
4.2. By Cytokine
4.3. By Tumor Suppressor
4.4. By Suicide
4.5. By Deficiency
4.6. By Growth Factors
4.7. By Receptors
5. North America Gene Therapy Market - by Application
5.1. By Oncological Disorders
5.2. By Rare Diseases
5.3. By Cardiovascular Diseases
5.4. By Neurological Disorders
5.5. By Infectious Disease
Chapter 5 Europe Gene Therapy Market - Segment Analysis
1. Overview
2. Europe Gene Therapy Market, 2021 - 2034 (USD Million)
3. Europe Gene Therapy Market - by Vector Type
3.1. By Viral Vector
3.2. By Non-Viral Vector
4. Europe Gene Therapy Market - by Gene Type
4.1. By Antigen
4.2. By Cytokine
4.3. By Tumor Suppressor
4.4. By Suicide
4.5. By Deficiency
4.6. By Growth Factors
4.7. By Receptors
5. Europe Gene Therapy Market - by Application
5.1. By Oncological Disorders
5.2. By Rare Diseases
5.3. By Cardiovascular Diseases
5.4. By Neurological Disorders
5.5. By Infectious Disease
Chapter 6 Asia Pacific Gene Therapy Market - Segment Analysis
1. Overview
2. Asia Pacific Gene Therapy Market, 2021 - 2034 (USD Million)
3. Asia Pacific Gene Therapy Market - by Vector Type
3.1. By Viral Vector
3.2. By Non-Viral Vector
4. Asia Pacific Gene Therapy Market - by Gene Type
4.1. By Antigen
4.2. By Cytokine
4.3. By Tumor Suppressor
4.4. By Suicide
4.5. By Deficiency
4.6. By Growth Factors
4.7. By Receptors
5. Asia Pacific Gene Therapy Market - by Application
5.1. By Oncological Disorders
5.2. By Rare Diseases
5.3. By Cardiovascular Diseases
5.4. By Neurological Disorders
5.5. By Infectious Disease
Chapter 7 Latin America Gene Therapy Market - Segment Analysis
1. Overview
2. Latin America Gene Therapy Market, 2021 - 2034 (USD Million)
3. Latin America Gene Therapy Market - by Vector Type
3.1. By Viral Vector
3.2. By Non-Viral Vector
4. Latin America Gene Therapy Market - by Gene Type
4.1. By Antigen
4.2. By Cytokine
4.3. By Tumor Suppressor
4.4. By Suicide
4.5. By Deficiency
4.6. By Growth Factors
4.7. By Receptors
5. Latin America Gene Therapy Market - by Application
5.1. By Oncological Disorders
5.2. By Rare Diseases
5.3. By Cardiovascular Diseases
5.4. By Neurological Disorders
5.5. By Infectious Disease
Chapter 8 Middle East & Africa Gene Therapy Market - Segment Analysis
1. Overview
2. Middle East & Africa Gene Therapy Market, 2021 - 2034 (USD Million)
3. Middle East & Africa Gene Therapy Market - by Vector Type
3.1. By Viral Vector
3.2. By Non-Viral Vector
4. Middle East & Africa Gene Therapy Market - by Gene Type
4.1. By Antigen
4.2. By Cytokine
4.3. By Tumor Suppressor
4.4. By Suicide
4.5. By Deficiency
4.6. By Growth Factors
4.7. By Receptors
5. Middle East & Africa Gene Therapy Market - by Application
5.1. By Oncological Disorders
5.2. By Rare Diseases
5.3. By Cardiovascular Diseases
5.4. By Neurological Disorders
5.5. By Infectious Disease
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Adaptimmune Therapeutics Plc.
2. Anchiano Therapeutics Ltd.
3. Achieve Life Sciences Inc.
4. Adverum Biotechnologies Inc.
5. Abeona Therapeutics Inc.
6. Applied Genetic Technologies Corporation
7. Arbutus Biopharma Corporation
8. Audentes Therapeutics Inc.
9. AveXis Inc.
10. Bluebird Bio Inc.
11. Celgene Corporation
12. CRISPR Therapeutics AG
13. Editas Medicine Inc.
14. Editas Medicine Inc.
15. GlaxoSmithKline Plc.
16. Intellia Therapeutics Inc.
17. Merck & Co. Inc.
18. Novartis AG
19. REGENXBIO Inc.
20. Spark Therapeutics Inc.
21. Sangamo Therapeutics Inc.
22. Uniqure N. V.
23. Voyager Therapeutics Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By